Article summary
Law360: The UK Competition Appeal Tribunal (CAT) refused on 21 June 2024 to apply a much more restrictive statute of limitations that would dismiss government claims that Danish pharmaceutical company Lundbeck Ltd and generic drug manufacturers anticompetitively agreed to delay generic competition to an antidepressant.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial